Aggregated
No track record data- Bullish
- 5
- Hold
- 3
- Bearish
- 0
Morgan Stanley
A Morgan Stanley analyst with 12 tracked ratings spanning 9 distinct tickers has a 4.6-star track record and a 66.7% success rate on the captured sample.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| MNPR | 2026-05-18 | buy | $115.00 | Aggregated |
| RARE | 2026-05-06 | buy | $67.00 | Aggregated |
| INSM | 2026-04-07 | buy | $212.00 | Aggregated |
| TCRX | 2026-03-11 | hold | - | Aggregated |
| MNPR | 2026-01-09 | buy | $115.00 | Aggregated |
| CRNX | 2026-01-08 | buy | $87.00 | Aggregated |
| CDTXCIDARA THERAPEUTICS INC | 2025-10-16 | unknown | $190.00 | Aggregated |
| ADAG | 2025-08-22 | hold | - | Aggregated |
| ASND | 2025-07-03 | buy | $250.00 | Aggregated |
| SANA | 2025-07-03 | buy | $12.00 | Aggregated |
| TCRX | 2025-03-14 | buy | $10.00 | Aggregated |
| IVVDINVIVYD INC | 2024-11-20 | unknown | $3.55 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| MNPR | 2 | 2026-05-18 | Aggregated |
| RARE | 1 | 2026-05-06 | Aggregated |
| INSM | 2 | 2026-04-07 | Aggregated |
| TCRX | 2 | 2026-03-11 | Aggregated |
| CRNX | 1 | 2026-01-08 | Aggregated |
| CDTXCIDARA THERAPEUTICS INC | 1 | 2025-10-16 | Aggregated |
| ADAG | 2 | 2025-08-22 | Aggregated |
| ASND | 1 | 2025-07-03 | Aggregated |
| SANA | 1 | 2025-07-03 | Aggregated |
| IVVDINVIVYD INC | 1 | 2024-11-20 | Aggregated |